EFSA Considering New CBD Toxicity Data While Clock-Stop Causes Industry ‘Economic Harm’
The European Food Safety Authority is evaluating new reproductive and developmental toxicity data published since it paused CBD novel food applications last year due to safety concerns, according to food law consultancy, Legal Foods.
You may also be interested in...
The UK Food Standards Agency has issued new advice aimed at consumers warning them not to take more than 10mg CBD per day, an acceptable daily intake level significantly lower than the agency's previous ADI of 70mg per day. However, CBD brand owners should not reformulate their products, Canna Consultants warns, as this would be a breach of FSA's conditions for remaining on the market.
Titanium dioxide stakeholders argued successfully in the Court of Justice of the European Union that TiO2’s hazard classification in 2020 under the CLP was based on shoddy science and a flawed interpretation of EU law. The industry win comes as the European Commission is finalizing a regulation to establish new CLP hazard classes, including for endocrine disruptors.
All European Union CBD novel food applications have been paused by EFSA after its Panel on Nutrition, Novel Foods and Food Allergens raised concerns about the ingredient's safety, pointing in a wide-ranging scientific literature review to a number of data gaps related to bioavailability, liver damage, gastrointestinal issues and possible negative impacts on pregnancy and reproductive health.